cddp

solute carrier family 31 member 1 ; Homo sapiens







13 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34201235 Targeting the Copper Transport System to Improve Treatment Efficacies of Platinum-Containing Drugs in Cancer Chemotherapy. 2021 Jun 8 1
2 34521054 ZNF711 down-regulation promotes CISPLATIN resistance in epithelial ovarian cancer via interacting with JHDM2A and suppressing SLC31A1 expression. 2021 Sep 2
3 25927922 EGCG Enhances Cisplatin Sensitivity by Regulating Expression of the Copper and Cisplatin Influx Transporter CTR1 in Ovary Cancer. 2015 2
4 26004625 Targeting drug transport mechanisms for improving platinum-based cancer chemotherapy. 2015 2
5 25594011 Integrin αV modulates the cellular pharmacology of copper and cisplatin by regulating expression of the influx transporter CTR1. 2014 2
6 23053666 Claudin-3 and claudin-4 regulate sensitivity to cisplatin by controlling expression of the copper and cisplatin influx transporter CTR1. 2013 Jan 2
7 23493492 Hyperthermic potentiation of cisplatin by magnetic nanoparticle heaters is correlated with an increase in cell membrane fluidity. 2013 2
8 23543413 A re-evaluation of the role of hCTR1, the human high-affinity copper transporter, in platinum-drug entry into human cells. 2013 Jun 2
9 24122978 Overcoming platinum drug resistance with copper-lowering agents. 2013 Oct 3
10 22914438 Mechanistic basis for overcoming platinum resistance using copper chelating agents. 2012 Nov 3
11 20451502 The role of the N-terminus of mammalian copper transporter 1 in the cellular accumulation of cisplatin. 2010 Aug 15 4
12 20519567 The role of the methionines and histidines in the transmembrane domain of mammalian copper transporter 1 in the cellular accumulation of cisplatin. 2010 Sep 7
13 19570948 Mechanistic comparison of human high-affinity copper transporter 1-mediated transport between copper ion and cisplatin. 2009 Oct 6